dr reddy's glp-1 drugs portfolio 2025 Three major Indian pharmaceutical companies - Sun Pharma, Zydus Lifesciences, and Dr. GLP-1 Market in India: From

This indicates that while higher doses may have some impact on kidney function, this effect is reversible and does not occur at lower, more commonly used doses

Wegovy has been approved to reduce the risk of major heart problems, and in August Lilly released data showing the heart-protective qualities of the diabetes treatment Mounjaro, which has the same main ingredient as Zepbound

Vitamin B12 can also help to prevent megaloblastic anemia, which is a blood condition that makes people severely tired and weak

Eli Lillys New Record: Retatrutide Brings Weight Loss Close to 30% The Phase 3 clinical trial of Retatrutide began on July 10, 2023

Methylcobalamin is one of the active coenzyme forms of B12 found in the human body